The Randomised Uterine Septum Transsection Trial
- Conditions
- Septated Uterus.Congenital malformation of uterus and cervix, unspecified
- Registration Number
- IRCT2016112331052N1
- Lead Sponsor
- Avicenna Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 68
Infertile women who visited in Avicenna Research center and 6 medical centers in netherland ; The trial will include women with a septate uterus and an active wish to conceive. A septate uterus is defined as a uterus with a division (septum) of the uterine cavity, without any restrictions to the length of the septum. The external contour of the
uterus should not have an indentation; Having satiafaction about participating in this study . Exclusion criteria:Women with contraindication for surgery
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ive birth after 24 weeks pregnancy. Timepoint: Live birth at least 24 weeks of gestational age within one year after surgery. Method of measurement: Sonography and clinical visits and notes.
- Secondary Outcome Measures
Name Time Method terine perforation during intervetion. Timepoint: During hysteroscopic metroplasty of septated uterus. Method of measurement: Clinical findings,hysteroscopic findings,sonographic findings.;Abortion. Timepoint: Within one year of intervention. Method of measurement: Clinical findings.;Week of pregnancy that abortion occured. Timepoint: Within 1 years after intervention. Method of measurement: Week of pregnancy.;Uterine perforation in pregnancy after intervention. Timepoint: During pregnancy within one year of intervention. Method of measurement: Clinical findings.;Preterm labor. Timepoint: Within one year of intervention. Method of measurement: Weeks of pregnancy.;Clinical pregnancy. Timepoint: Within1 years after intervention. Method of measurement: Sonography.;Endometritis. Timepoint: Till 6 weeks after intervention. Method of measurement: Clinical findings.;Maternal death during pregnancy. Timepoint: Within one year after intervention. Method of measurement: Clinical findings.